Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA94987
Max Phase: Preclinical
Molecular Formula: C20H24N2
Molecular Weight: 292.43
Molecule Type: Small molecule
Associated Items:
ID: ALA94987
Max Phase: Preclinical
Molecular Formula: C20H24N2
Molecular Weight: 292.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C(#Cc1cc[nH]c1)CCN1CCC(Cc2ccccc2)CC1
Standard InChI: InChI=1S/C20H24N2/c1-2-6-18(7-3-1)16-19-10-14-22(15-11-19)13-5-4-8-20-9-12-21-17-20/h1-3,6-7,9,12,17,19,21H,5,10-11,13-16H2
Standard InChI Key: GXBHAMNCULDZSF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 292.43 | Molecular Weight (Monoisotopic): 292.1939 | AlogP: 3.71 | #Rotatable Bonds: 4 |
Polar Surface Area: 19.03 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.07 | CX LogP: 4.47 | CX LogD: 2.80 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.85 | Np Likeness Score: -0.57 |
1. Wright JL, Gregory TF, Boxer PA, Meltzer LT, Serpa KA, Wise LD.. (1999) Discovery of subtype-selective NMDA receptor ligands: 4-benzyl-1-piperidinylalkynylpyrroles, pyrazoles and imidazoles as NR1A/2B antagonists., 9 (19): [PMID:10522697] [10.1016/s0960-894x(99)00482-5] |
Source(1):